Global Bioservices Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2025 –2032 |
 Market Size (Base Year) |
USD 156.65 Billion |
 Market Size (Forecast Year) |
USD 479.20 Billion |
 CAGR |
% |
| Major Markets Players |
|
全球生物服务市场，按行业（临床研究组织 (CRO)、合同制造商组织 (CMO) 和合同研究与制造服务 (CRAMS)、研究（制药、生物技术、学术、临床试验和医疗保健领域）应用领域（捐赠者招募、组织收集、细胞处理和分离、研究与开发）划分 - 行业趋势和预测至 2029 年
市场分析和规模
回顾过去几年，备受瞩目和热捧的生物服务行业几乎已经发挥出了其最初的潜力。生物服务收入和数量数据包括合同制造、合同研究和临床研究。许多行业分析师和领导者对生物服务行业的潜力和前景持乐观态度。例如，几年前，大约有 120 项临床研究被分包给印度，但只有大约 11 项在印度临床试验注册中心 (CTRI) 正式注册。目前，印度正在进行 600 项创新药物、医疗器械、疗法和外科手术试验。凭借固有的成本效益和大量投资与整合，生物制药制造商和研究实验室在新地点建立新机构和子公司以及临床数据管理，预计将为该行业的全球增长带来良好预兆。
Data Bridge Market Research 分析，生物服务市场在 2021 年为 1030 亿美元，到 2029 年将飙升至 3150.8 亿美元，预计在 2022 年至 2029 年的预测期内复合年增长率为 15%。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外，Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、管道分析、定价分析和监管框架。
报告范围和市场细分
|
报告指标 |
细节 |
|
预测期 |
2022 至 2029 年 |
|
基准年 |
2021 |
|
历史岁月 |
2020（可定制为 2014 - 2019） |
|
定量单位 |
收入（单位：十亿美元）、销量（单位：台）、定价（美元） |
|
涵盖的领域 |
行业（临床研究组织 (CRO)、合同制造商组织 (CMO) 和合同研究与制造服务 (CRAMS)、研究（制药、生物技术、学术、临床试验和医疗保健领域）应用领域（捐赠者招募、组织收集、细胞处理和分离、研究与开发） |
|
覆盖国家 |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
|
Market Players Covered |
Novartis AG (Switzerland), SIRO Clinpharm Private Limited (India)Thermo Fisher Scientific Inc. (U.S), Bruker (U.S), PerkinElmer, Inc. (U.S), Agilent Technologies, Inc. (U.S), Eurofins Scientific (Luxembourg), Danaher (U.S), Merck KGaA (Germany), Siemens Healthcare GmbH (Germany), Medtronic (Ireland), ABB (Sweden),B&W Tek. (U.S), Digilab Inc. (U.S) |
|
Market Opportunities |
|
Market Definition
Bioservices are aids and services provided to clinical trials, healthcare sectors, biotech enterprises, and educational startegies in order to increase support and research so that these entities can channel and strengthen their research progress. To assist the biotechnology business, the bioservices market includes experimenting with various cell-based instruments and equipment, phase of development, clinical examination, and scientific research and analysis.
Bioservices Market Dynamics
Drivers
- Rising volume of suffering patients
The urgent need for sophisticated medical services and government attempts to provide financial and capital assistance to clinical research centres are sowing the seeds of future growth in the bioservices industry and market. The market outlook and analyst insights predict that big biotech and pharmaceutical companies will experience significant growth in the next years. As a result of these reasons, the bioservices industry is expected to grow vertically from 2022 to 2029. The rise of the bioservices sector is mostly due to cheap labour costs and low input costs.
- Outsourcing of clinical trials
Drug discovery and contract manufacturing have recently become popular in numerous affluent economies. As a result, the bio-services market in developing nations like China, Thailand, Malaysia, and India is expanding rapidly. These countries invest in research and development programmes to produce innovative bio-services. Bio-services have potential opportunities in emerging economies because of government regulatory support, accessible raw material availability, and cheap labour. Because of its cheap operational costs, the worldwide bio-service business is expected to outperform other biotechnology applications. Various institutions and companies are investing in research and development projects in order to minimise the time it takes for clinical trials to complete. This is one of the primary driving factors of the global bio-services industry.
- Increasing awareness about minimally invasive treatments
The advancement of bioengineering technologies and the growing population of the elderly are driving the worldwide bioimplants market forward. For example, a significant portion of the elderly population requires dental implants for restorative therapy, fueling the demand for dental bioimplants. Furthermore, several lifestyle-related chronic conditions such as rheumatoid arthritis, cardiovascular disease, and metabolic disorders have increased the need for bioimplants around the world.
Opportunities
In the upcoming years, it is projected that major pharmaceutical and biotech corporations worldwide would slant their selections in favour of comprehensive value service providers of bio-services rather than focusing solely on incurring expenses. This is critical when making decisions that effect strategic benefits rather than cost-driven or short-term objectives. IT services required for clinical data management and validation capabilities are predicted to boost the global bio-services market's growth beyond the bioequivalence and bioavailability studies that now dominate the industry. Possibly the utmost inspiring aspect for this sector is that it rides on an optimistic macro-environment and development outlook of the complete biotech industry.
Restraints/Challenges
The lack of high-skilled and efficient personnel will stifle market growth, while high-cost input and a slow pace of solid development will stifle market germination over the anticipated period of time.
本生物服务市场报告详细介绍了最新发展、贸易法规、进出口分析、生产分析、价值链优化、市场份额、国内和本地市场参与者的影响，分析了新兴收入领域的机会、市场法规的变化、战略市场增长分析、市场规模、类别市场增长、应用领域和主导地位、产品批准、产品发布、地域扩展、市场技术创新。如需了解有关生物服务市场的更多信息，请联系 Data Bridge Market Research 获取分析师简报，我们的团队将帮助您做出明智的市场决策，实现市场增长。
近期发展
- 2019年12月，TriNetX与EvidNet的合并可视化了一个具体的例子，通过此次收购，总部位于美国的临床研究公司TriNetx扩大了其在韩国的投资组合，将增加3600万名患者和囚犯的医疗保健数据。
- 2019 年 12 月，全球领先的生物服务公司 Avantor, Inc 在中国上海开设了一个先进而独特的客户支持中心，以增加其在活体人类学和高水平技术研究服务方面的持股。此次并购将促进为生物制药公司服务的实验室的创建。
全球生物服务市场范围
生物服务市场根据行业、研究和应用领域进行细分。这些细分市场之间的增长情况将帮助您分析行业中增长缓慢的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。
行业
- 临床研究组织 (CRO)
- 合同制造商组织 (CMO)
- 合同研究与制造服务 (CRAMS)
研究
- 制药
- 生物技术
- 学术的
- 临床试验
- 医疗保健领域
应用领域
- 捐赠者招募
- 组织收集
- 细胞处理和分离
- 研究与开发
生物服务市场区域分析/见解
对生物服务市场进行了分析，并按上述国家、行业、研究和应用领域提供了市场规模见解和趋势。
生物服务市场报告涵盖的国家包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区的亚太其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲其他地区、巴西、阿根廷以及南美洲的其他地区。
由于大量政府举措和国家投资开展富有创造性和进步性的研究交易和项目，北美在生物服务市场占据主导地位。
由于新兴国家和发展中经济体的预期需求，预计亚太地区 (APAC) 在 2022 年至 2029 年预测期内将以最高增长率增长。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
医疗保健基础设施增长安装基础和新技术渗透
生物服务市场还为您提供每个国家/地区资本设备医疗支出增长、生物服务市场不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗监管情景的变化及其对生物服务市场的影响的详细市场分析。数据涵盖 2010-2020 年的历史时期。
竞争格局和生物服务市场份额分析
生物服务市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对生物服务市场的关注有关。
生物服务市场的一些主要参与者包括：
- 诺华公司（瑞士）
- SIRO Clinpharm Private Limited（印度）
- 赛默飞世尔科技公司（美国）
- 布鲁克 (美国)
- PerkinElmer, Inc.（美国）
- 安捷伦科技公司（美国）
- Eurofins Scientific（卢森堡）
- 丹纳赫（美国）
- 默克集团（德国）
- 西门子医疗有限公司（德国）
- 美敦力（爱尔兰）
- ABB（瑞典）
- B&W Tek.（美国）
- Digilab Inc. （美国）
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
